The success of cardiac resynchronization therapy (CRT) depends on a high percentage of ventricular pacing. We present the electrocardiography and electrograms of a patient who underwent an implantable cardioverter-defibrillator (ICD) with CRT implantation showing a low percentage of ventricular pacing as a result of T wave oversensing of paced QRS. The patient showed no clinical improvement. We suggest finding a good sensitivity of F waves in induced ventricular fibrillation during ICD implantation in order to overcome the harm of possible oversensing.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
P-Wave Oversensing by the Implantable Cardiac Monitor During Paroxysmal Atrioventricular Block: What Is the Mechanism?
J Cardiovasc Electrophysiol
December 2024
Department of Cardiology, Asia Medical Group, Sapporo Heart Center, Sapporo Cardiovascular Clinic, Sapporo, Hokkaido, Japan.
Introduction: The novel Confirm Rx™ implantable cardiac monitor (ICM) with SharpSense™ technology incorporates a new P-wave discriminator designed to improve AF detection. This study aimed to evaluate the diagnostic performance of the Confirm Rx™ ICM in detecting AF episodes of varying durations.
Methods: We conducted a multicenter retrospective analysis of consecutive patients implanted with a Confirm Rx™ ICM (v1.
Synthesized V7 QRS Amplitude and Oversensing Episodes in Patients With Subcutaneous Implantable Cardioverter-Defibrillators.
Pacing Clin Electrophysiol
December 2024
Department of Cardiology, Anjo Kosei Hospital, Anjo, Japan.
Article Synopsis
- Patients with subcutaneous implantable cardioverter-defibrillators (S-ICDs) experience oversensing episodes (OS) more frequently than those with traditional transvenous ICDs, indicating a need for better detection methods.
- A study of 21 patients found that 28.6% experienced OS, particularly among those with Brugada/J wave syndrome, and determined that a significantly lower QRS amplitude in the synthesized V7 lead (synV7) was linked to OS incidence.
- The study suggests that a synV7 QRS amplitude of less than 0.61 mV can effectively predict the occurrence of OS, highlighting the need for monitoring this parameter in patients with S-ICDs.
Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.
Circulation
September 2024
Christchurch Hospital, Christchurch, New Zealand.
Article Synopsis
- The study evaluates the long-term performance and safety of the extravascular implantable cardioverter-defibrillator (EV ICD) after initial findings showed its effectiveness for 6 months.
- A total of 316 patients were enrolled, with a successful implant in 299 cases, experiencing various arrhythmic events that were effectively treated using antitachycardia pacing (ATP) and shocks.
- The results indicated high success rates for both ATP (77.1%) and shock therapy (100%), with low rates of complications and inappropriate shocks over the three-year study period.
Feasibility, safety, and short-term follow-up of defibrillator lead at left bundle branch area pacing location: A pilot study.
Heart Rhythm
October 2024
Geisinger Heart Institute, Geisinger Commonwealth School of Medicine, Wilkes Barre, Pennsylvania.
Article Synopsis
- Left bundle branch area pacing (LBBAP) shows promise as a safe and effective alternative for cardiac resynchronization therapy (CRT) in patients with implantable cardioverter-defibrillators (ICD).
- A study assessed the feasibility and safety of a traditional defibrillator lead in the LBBAP location, finding a 62.5% acute procedural success rate with some patients needing lead repositioning.
- Follow-up results for an average of 3.8 months indicated stable pacing parameters with no inappropriate arrhythmia detection or therapy issues, supporting LBBAP as a viable option.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!